Phenominer Database Results (4 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Experiment Notes Record ID Study ID
ACI/SegHsd percentage of study population developing experimental autoimmune neuritis during a period of time peripheral myelin protein 2 peptide 58-81 (100 ug) and Freund's complete adjuvant (100 ul) de Graaf KL, et al., J Neuroimmunol. 2004 Oct;155(1-2):73-84. peripheral nervous system integrity trait male 98.0 days-200.0 days 4 0.0 % ex vivo visual assessment 0.0 peripheral nervous system integrity trait 84524 1178
ACI/SegHsd percentage of study population developing experimental autoimmune neuritis during a period of time peripheral nerve myelin (2 mg) and Freund's complete adjuvant (100 ul) de Graaf KL, et al., J Neuroimmunol. 2004 Oct;155(1-2):73-84. peripheral nervous system integrity trait male 98.0 days-200.0 days 4 0.0 % ex vivo visual assessment 0.0 peripheral nervous system integrity trait 84474 1178
ACI/SegHsd percentage of study population developing pituitary tumors during a period of time 17 beta-estradiol (27.5 mg) (between 146 and 202 days) Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 pituitary gland integrity trait female 207.0 days-265.0 days 21 100.0 % ex vivo visual assessment 0 65551 76
ACI/SegHsd percentage of study population developing pituitary tumors during a period of time bilateral ovariectomy then 17 beta-estradiol (27.5 mg) (for 140 days) Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 pituitary gland integrity trait female 201.0 days-203.0 days 11 100.0 % ex vivo visual assessment 0 65561 76